Pilot study to investigate dietary supplementation of elderly COPD patients with an oral nutritional supplement enriched with n-3 polyunsaturated fatty acids and its effect on respiratory function, appetite and weight
Not Applicable
Completed
- Conditions
- Chronic obstructive pulmonary disease (COPD)RespiratoryOther chronic obstructive pulmonary disease
- Registration Number
- ISRCTN16343749
- Lead Sponsor
- Department of Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Out patients from COPD clinic at the Hammersmith Hospitals NHS Trust
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link n-3 PUFA supplementation to improved respiratory function in COPD patients?
How does n-3 PUFA supplementation compare to standard nutritional support in COPD patient outcomes?
Which biomarkers predict response to n-3 PUFA-enriched oral nutritional supplements in elderly COPD patients?
What are the potential adverse events associated with long-chain omega-3 fatty acid supplementation in COPD?
How do n-3 PUFA supplements interact with bronchodilators and anti-inflammatory therapies in COPD management?